维普中文期刊产品整合服务
62篇 您的检索式:作者名="SCARTOZZI R"
    题名 作者 年代 出处 被引量
1Survey of 1 264 patients with orbital tumors and simulating lesions:The 2002 Montgomery lecture显示文摘Shields JA Shieldscl Scartozzi R 2004Ophthalmology2004,111,5:1
2Phosphorylated Akt and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab显示文摘Scartozzi M Giampieri R Maccaroni E 2012J Transl Med2012,10,1:1
3Survey of 1264 patients with orbital tumors and simulating lesions:The 2002 Montgomery Lecture,Part1显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,5:1
4Survey of 1264 patients with orbital tumors and simulating lesions:the 2002 Montgomery Lecture,part 1显示文摘SHIELD J A SHIELDS C L SCARTOZZI R 2004Ophthalmology2004,111,5:1
5Intraoperative Sclerotomy-related Retinal Breaks for Macular Surgery,20-vs 25-Gauge Vitrectomy Systems显示文摘Scartozzi R Bessa AS Gupta OP 2007Am J Ophthalmol2007,143,:1
6High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)显示文摘Cascinu S Scartozzi M Labianca R 2004Brit J Cancer2004,90,8:1
7Clinical predictive factors for advanced non-small cell lung cancer(NSCLC) patients receiving third-linetherapy:Seecting the unseleetable?显示文摘Scartozzi M Mazzanti P Giampieri R 2010Lung Cancer2010,68,3:1
8High curativeresection rate with weekly cisplatin,5-fluorouracil,epidoxorubicin,6S-leucovorin,glutathione,and filgastrimin patients with locally advanced,unresectable gastric cancer:a report from the Italian Group for the Study of Digestive Tract C显示文摘Cascinu S Scartozzi M Labianca R 0,,08:1
9Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab- based therapy in metastatic colorectal cancer patients显示文摘Scartozzi M Giampieri R Maccaroni E 2012Br J Cancer2012,106,5:1
10Survery of 1264 patients with orbita 1 tumors and simulating lesions显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,:1
11Gastric cancer treament : a systematic review 显示文摘Berardi R Scartozzi M Romagnoli E 2004Oncol Rep2004,11,4:1
12Survey of 1264 patients with orbital tumors and simulating lesions显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,:1
13Survey of 1264 patients with orbital tumors and simulating lesions 显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmlogy2004,111,5:1
14Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery Lec- ture, part 1 显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,5:1
15Epidermal growth factor receptor (EGFR) status in primary eolorectal tumors does not correlate with EGFR expression in related metastatic sites : implications for treatment with EGFR-targeted monoclonal antibodies 显示文摘Scartozzi M Bearzi I Berardi R 2004J Clin Oncol2004,22,23:1
16High curative resection rate with weekly cisplatin,5-fluorouracil,epidoxorubicin,6S-leucovorin,glutathione,and filgastrim in patients with locally advanced,unresectable gastric cancer:a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)显示文摘Cascinu S Scartozzi M Labianca R 2004Br J Cancer2004,90,8:1
17Survery of 1 264 patients with orbital tumors and simulating lesions显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,:1
18Molecular biomarkers of resistance to anti-EGFR treatment in metastatic colorectal cancer,from classical to innovation显示文摘Giampieri R Scartozzi M Del Prete M 2013Crit Rev Oncol Hematol2013,88,2:1
19Survey of 1264 patients with orbital tumors and simulating lesions显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,:1
20Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1 显示文摘Shields JA Shields CL Scartozzi R 2004Ophthalmology2004,111,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费